Literature DB >> 1573423

Neurological long-term follow-up in left atrial myxoma: are late complications frequent or rare?

H Reichmann1, R Romberg-Hahnloser, E Hofmann, T Becker, H G Mertens.   

Abstract

Neurological manifestations were analysed in 13 patients with left atrial myxoma confirmed by histological study. In this group, 6 patients had neurological complaints at initial presentation, 5 had cardiac symptoms, and 4 patients presented with signs of systemic disease. CT was performed in 10 and MRI in 7 patients. There were signs of ischaemic or haemorrhagic infarction (6 of 12) and one lesion suggestive of myxoma metastasis; other findings mainly comprised non-specific white matter lesions revealed by MRI. Neurological follow-up 0.5-8 years after tumour resection revealed no delayed neurological complications, follow-up CT and MRI findings were not suggestive of lesions acquired after operation. It is suggested that this rare condition of cardiac myxoma should be suspected in young patients with CNS symptoms or signs lacking cerebrovascular or cardiovascular risk factors and should be included in the differential diagnosis of vasculitis. With timely diagnosis and resection of the cardiac tumour the long-term prognosis can be considered improved.

Entities:  

Mesh:

Year:  1992        PMID: 1573423     DOI: 10.1007/bf00833920

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  43 in total

1.  Diagnosis of left atrial myxoma.

Authors:  J F GOODWIN
Journal:  Lancet       Date:  1963-03-02       Impact factor: 79.321

2.  The syndrome of fever, anaemia, and high sedimentation rate with an atrial myxoma.

Authors:  G A MACGREGOR; R A CULLEN
Journal:  Br Med J       Date:  1959-11-14

3.  An unusual cause of recurrent transient neurologic deficit.

Authors:  M P Rozear; W G Wolfe
Journal:  N C Med J       Date:  1985-07

4.  Cerebral angiography in cardiac myxoma. Correlation of angiographic and histopathological findings.

Authors:  P F New; D L Price; B Carter
Journal:  Radiology       Date:  1970-08       Impact factor: 11.105

5.  Embolism to the central nervous system from cardiac myxoma. Report of two cases.

Authors:  B K Tipton; J T Robertson; J H Robertson
Journal:  J Neurosurg       Date:  1977-12       Impact factor: 5.115

6.  Malignant cardiac myxoma with cerebral metastases.

Authors:  G Budzilovich; S Aleksic; A Greco; J Fernandez; J Harris; M Finegold
Journal:  Surg Neurol       Date:  1979-06

7.  Cerebral aneurysms and cardiac myxoma.

Authors:  C G Gonsalves; A C Nidecker
Journal:  J Can Assoc Radiol       Date:  1979-06

8.  The pathogenesis of peripheral aneurysms of the central nervous system: a subject review from the AFIP.

Authors:  W W Olmsted; T P McGee
Journal:  Radiology       Date:  1977-06       Impact factor: 11.105

9.  Subsequent neurological events in patients with atrial myxoma.

Authors:  B A Sandok; I von Estorff; E R Giuliani
Journal:  Ann Neurol       Date:  1980-09       Impact factor: 10.422

Review 10.  Atrial myxomas: results of 25 years' experience and review of the literature.

Authors:  S Larsson; V Lepore; C Kennergren
Journal:  Surgery       Date:  1989-06       Impact factor: 3.982

View more
  3 in total

1.  Cerebral embolism from left atrial myxoma leading to cerebral and retinal aneurysms: a case report.

Authors:  Martin Herbst; Mike Peter Wattjes; Horst Urbach; Claudia Inhetvin-Hutter; Dietmar Becker; Thomas Klockgether; Alexander Hartmann
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

Review 2.  Surgical treatment of primary intracranial myxoma in a child following radiotherapy: case report and review of the literature.

Authors:  Oliver M Mueller; Johannes A P van de Nes; Regina Wieland; Beate Schoch; Ulrich Sure
Journal:  Childs Nerv Syst       Date:  2009-11-28       Impact factor: 1.475

3.  Cardiac myxomas: a long term study.

Authors:  H P Mattle; D Maurer; M Sturzenegger; C Ozdoba; R W Baumgartner; G Schroth
Journal:  J Neurol       Date:  1995-10       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.